文献速递白血病

全基因组研究识别与儿童急性淋巴细胞白血病骨毒性相关的新基因

Genome-wide study identifies novel genes associated with bone toxicities in children with acute lymphoblastic leukaemia.
PubMed 文献 · Br J Haematol · 2024-08-14

在DFCI 05-001试验260例欧洲裔急性淋巴细胞白血病(ALL)患儿中开展全基因组关联研究(GWAS)和转录组全关联研究(TWAS),并在DFCI 11-001试验101例欧洲裔患儿中验证;发现染色体20上rs844882与骨毒性显著相关(p=1.7×10⁻⁸),ACAD9表达与骨毒性风险增加相关,跟骨定量超声声速多基因风险评分与骨折风险相关。

要点

  • rs844882与DFCI 05-001试验中骨毒性显著相关(p=1.7×10⁻⁸),DFCI 11-001试验中与骨折呈一致趋势。
  • rs844882为邻近基因CD93和THBD的eQTL;TWAS显示遗传预测的ACAD9表达与骨毒性风险增加相关(meta-p=2.4×10⁻⁶)。
  • 跟骨定量超声声速多基因风险评分与两个队列骨折风险相关(meta-p=2.3×10⁻³)。

核心结论

  • 研究结果强调遗传因素对ALL患儿治疗相关骨毒性的影响,所识别基因为了解ALL治疗相关骨不良事件的发生提供新的生物学线索。

研究设计与样本

  • 在DFCI 05-001 ALL试验260例欧洲裔患者中开展GWAS和TWAS,并在DFCI 11-001 ALL试验101例欧洲裔患者中验证。

主要发现

  • DFCI 05-001试验中染色体20上rs844882与骨毒性显著相关(p=1.7×10⁻⁸),DFCI 11-001试验中该变异与骨折呈一致趋势。
  • rs844882是邻近基因CD93和THBD的eQTL。
  • TWAS显示遗传预测的ACAD9表达与骨毒性风险增加相关,两队列meta分析确认(meta-p=2.4×10⁻⁶)。
  • 跟骨定量超声声速多基因风险评分与两队列骨折风险相关(meta-p=2.3×10⁻³)。

关键数值与推荐

  • 骨毒性关联:DFCI 05-001试验rs844882 p=1.7×10⁻⁸;DFCI 11-001试验中与骨折呈一致趋势。
  • ACAD9表达与骨毒性风险增加相关:两队列meta-p=2.4×10⁻⁶。
  • 跟骨定量超声声速多基因风险评分与骨折风险相关:两队列meta-p=2.3×10⁻³。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Bone toxicities are common among paediatric patients treated for acute lymphoblastic leukaemia (ALL) with potentially major negative impact on patients' quality of life. To identify the underlying genetic contributors, we conducted a genome-wide association study (GWAS) and a transcriptome-wide association study (TWAS) in 260 patients of European-descent from the DFCI 05-001 ALL trial, with validation in 101 patients of European-descent from the DFCI 11-001 ALL trial. We identified a significant association between rs844882 on chromosome 20 and bone toxicities in the DFCI 05-001 trial (p = 1.7 × 10-8). In DFCI 11-001 trial, we observed a consistent trend of this variant with fracture. The variant was an eQTL for two nearby genes, CD93 and THBD. In TWAS, genetically predicted ACAD9 expression was associated with an increased risk of bone toxicities, which was confirmed by meta-analysis of the two cohorts (meta-p = 2.4 × 10-6). In addition, a polygenic risk score of heel quantitative ultrasound speed of sound was associated with fracture risk in both cohorts (meta-p = 2.3 × 10-3). Our findings highlight the genetic influence on treatment-related bone toxicities in this patient population. The genes we identified in our study provide new biological insights into the development of bone adverse events related to ALL treatment.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Zhu Q, Nambiar R, Schultz E, et al. Genome-wide study identifies novel genes associated with bone toxicities in children with acute lymphoblastic leukaemia. Br J Haematol. 2024. PMID: 39143423. doi:10.1111/bjh.19696

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。